Solid Biosciences Inc. (SLDB)

USD 4.03

(-9.64%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 8.09 Million 13.62 Million - - -
Cost of Revenue 76.56 Million 2.4 Million 58.73 Million 3.92 Million 2.82 Million 1.56 Million
Gross Profit -76.56 Million 5.68 Million -45.11 Million -3.92 Million -2.82 Million -1.56 Million
Operating Expenses 104.31 Million 107.36 Million 85.87 Million 86.46 Million 119.31 Million 75.68 Million
Selling, General and Administrative Expenses 27.75 Million 28.94 Million 27.13 Million 21.58 Million 24.58 Million 17.72 Million
Research and Development Expenses 76.56 Million 78.42 Million 58.73 Million 64.88 Million 94.73 Million 57.96 Million
Other Expenses - -381 Thousand 2000.00 1.94 Million 515 Thousand 270 Thousand
Cost and Expenses 104.31 Million 107.36 Million 85.87 Million 86.46 Million 119.31 Million 75.68 Million
Operating Income -104.31 Million -106.45 Million -72.25 Million -88.4 Million -119.31 Million -75.68 Million
Interest Expense - - - - - -
Income Tax Expense - -20.47 Million -64 Thousand 1.82 Million -1.58 Million 889 Thousand
Earnings before Tax -96.01 Million -85.98 Million -72.18 Million -88.29 Million -117.22 Million -74.79 Million
Net Income -96.01 Million -65.51 Million -72.12 Million -90.11 Million -115.64 Million -74.79 Million
Earnings Per Share Basic -4.83 -7.70 -10.13 -26.03 -43.05 -33.73
Earnings Per Share Diluted -4.83 -7.70 -10.13 -26.03 -43.05 -33.73
Weighted Average Shares Outstanding 19.88 Million 8.51 Million 7.11 Million 3.46 Million 2.68 Million 2.21 Million
Weighted Average Shares Outstanding (Diluted) 19.88 Million 8.51 Million 7.11 Million 3.46 Million 2.68 Million 2.21 Million
Gross Margin - 0.70 -3.31 - - -
EBIT Margin - -13.33 -5.09 - - -
Profit Margin - -8.09 -5.30 - - -
EBITDA -93.43 Million -96.86 Million -69.29 Million -84.36 Million -116.49 Million -75.68 Million
Earnings Before Tax Margin - -13.15 -5.30 - - -

Income Statement Charts